Beam Therapeutics, Inc. (BEAM)
29.64
-2.65
(-8.21%)
USD |
NASDAQ |
Feb 25, 16:00
29.61
-0.03
(-0.10%)
After-Hours: 18:47
Beam Therapeutics Research and Development Expense (Quarterly) : 109.77M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 92.33M |
| Twist Bioscience Corp. | 17.13M |
| Pacific Biosciences of California, Inc. | 22.88M |
| Stryker Corp. | 380.00M |
| Zimmer Biomet Holdings, Inc. | 118.80M |